TScan Therapeutics, Inc.TCRXNASDAQ
Loading
SG&A Expenses Over TimeStrong
Percentile Rank100
3Y CAGR+15.6%
5Y CAGR+36.1%
Year-over-Year Change
Selling, general, and administrative expenses
3Y CAGR
+15.6%/yr
Annual compound
5Y CAGR
+36.1%/yr
Recent deceleration
Percentile
P100
Near historical high
vs 5Y Ago
4.7x
Strong expansion
Streak
6 yr
Consecutive growthStrong
| Period | Value | YoY Change |
|---|---|---|
| TTM | $31.46M | +6.4% |
| 2024 | $29.56M | +16.0% |
| 2023 | $25.49M | +25.3% |
| 2022 | $20.35M | +47.2% |
| 2021 | $13.83M | +105.1% |
| 2020 | $6.74M | +41.4% |
| 2019 | $4.77M | - |